Global Oral Live Attenuated Rotavirus Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Oral rotavirus live attenuated vaccine refers to an oral vaccine containing attenuated rotavirus pathogens with weakened pathogenicity.
The global Oral Live Attenuated Rotavirus Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Oral Live Attenuated Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Oral Live Attenuated Rotavirus Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Live Attenuated Rotavirus Vaccine sales for 2024 through 2030. With Oral Live Attenuated Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Live Attenuated Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral Live Attenuated Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Live Attenuated Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Live Attenuated Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Live Attenuated Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Live Attenuated Rotavirus Vaccine.
United States market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oral Live Attenuated Rotavirus Vaccine players cover Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Live Attenuated Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Oral Live Attenuated Rotavirus Vaccine market?
What factors are driving Oral Live Attenuated Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Live Attenuated Rotavirus Vaccine market opportunities vary by end market size?
How does Oral Live Attenuated Rotavirus Vaccine break out by Type, by Application?
Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Oral rotavirus live attenuated vaccine refers to an oral vaccine containing attenuated rotavirus pathogens with weakened pathogenicity.
The global Oral Live Attenuated Rotavirus Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Oral Live Attenuated Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Oral Live Attenuated Rotavirus Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Live Attenuated Rotavirus Vaccine sales for 2024 through 2030. With Oral Live Attenuated Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Live Attenuated Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral Live Attenuated Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Live Attenuated Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Live Attenuated Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Live Attenuated Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Live Attenuated Rotavirus Vaccine.
United States market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oral Live Attenuated Rotavirus Vaccine players cover Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Live Attenuated Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Vaccines
- Combination Vaccines
- Hospitals and Clinics
- Vaccination Sites
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck Sharp & Dohme
- GSK
- Bharat Biotech
- Lanzhou Biological Products Research Institute
What is the 10-year outlook for the global Oral Live Attenuated Rotavirus Vaccine market?
What factors are driving Oral Live Attenuated Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Live Attenuated Rotavirus Vaccine market opportunities vary by end market size?
How does Oral Live Attenuated Rotavirus Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Live Attenuated Rotavirus Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Live Attenuated Rotavirus Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Oral Live Attenuated Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Combination Vaccines
2.3 Oral Live Attenuated Rotavirus Vaccine Sales by Type
2.3.1 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Type (2019-2024)
2.4 Oral Live Attenuated Rotavirus Vaccine Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Vaccination Sites
2.5 Oral Live Attenuated Rotavirus Vaccine Sales by Application
2.5.1 Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Oral Live Attenuated Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Company (2019-2024)
3.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Product Location Distribution
3.4.2 Players Oral Live Attenuated Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Oral Live Attenuated Rotavirus Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Live Attenuated Rotavirus Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.4 APAC Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.5 Europe Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country
5.1.1 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
5.1.2 Americas Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
5.2 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
5.3 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region
6.1.1 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024)
6.1.2 APAC Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024)
6.2 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
6.3 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Live Attenuated Rotavirus Vaccine by Country
7.1.1 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
7.1.2 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
7.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
7.3 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Live Attenuated Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Oral Live Attenuated Rotavirus Vaccine
10.4 Industry Chain Structure of Oral Live Attenuated Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Live Attenuated Rotavirus Vaccine Distributors
11.3 Oral Live Attenuated Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ORAL LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Region (2025-2030)
12.1.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Type (2025-2030)
12.7 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck Sharp & Dohme
13.1.1 Merck Sharp & Dohme Company Information
13.1.2 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Sharp & Dohme Main Business Overview
13.1.5 Merck Sharp & Dohme Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 Lanzhou Biological Products Research Institute
13.4.1 Lanzhou Biological Products Research Institute Company Information
13.4.2 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Biological Products Research Institute Main Business Overview
13.4.5 Lanzhou Biological Products Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Live Attenuated Rotavirus Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Live Attenuated Rotavirus Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Oral Live Attenuated Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Combination Vaccines
2.3 Oral Live Attenuated Rotavirus Vaccine Sales by Type
2.3.1 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Type (2019-2024)
2.4 Oral Live Attenuated Rotavirus Vaccine Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Vaccination Sites
2.5 Oral Live Attenuated Rotavirus Vaccine Sales by Application
2.5.1 Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Oral Live Attenuated Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Company (2019-2024)
3.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Product Location Distribution
3.4.2 Players Oral Live Attenuated Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Oral Live Attenuated Rotavirus Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Live Attenuated Rotavirus Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.4 APAC Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.5 Europe Oral Live Attenuated Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country
5.1.1 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
5.1.2 Americas Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
5.2 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
5.3 Americas Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region
6.1.1 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024)
6.1.2 APAC Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024)
6.2 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
6.3 APAC Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Live Attenuated Rotavirus Vaccine by Country
7.1.1 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
7.1.2 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
7.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
7.3 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Live Attenuated Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Oral Live Attenuated Rotavirus Vaccine
10.4 Industry Chain Structure of Oral Live Attenuated Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Live Attenuated Rotavirus Vaccine Distributors
11.3 Oral Live Attenuated Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ORAL LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Region (2025-2030)
12.1.2 Global Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Type (2025-2030)
12.7 Global Oral Live Attenuated Rotavirus Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck Sharp & Dohme
13.1.1 Merck Sharp & Dohme Company Information
13.1.2 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Sharp & Dohme Main Business Overview
13.1.5 Merck Sharp & Dohme Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 Lanzhou Biological Products Research Institute
13.4.1 Lanzhou Biological Products Research Institute Company Information
13.4.2 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Biological Products Research Institute Main Business Overview
13.4.5 Lanzhou Biological Products Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oral Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Combination Vaccines
Table 5. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Oral Live Attenuated Rotavirus Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Oral Live Attenuated Rotavirus Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral Live Attenuated Rotavirus Vaccine Products Offered
Table 22. Oral Live Attenuated Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Oral Live Attenuated Rotavirus Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Oral Live Attenuated Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Oral Live Attenuated Rotavirus Vaccine
Table 53. Key Industry Trends of Oral Live Attenuated Rotavirus Vaccine
Table 54. Oral Live Attenuated Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral Live Attenuated Rotavirus Vaccine Distributors List
Table 57. Oral Live Attenuated Rotavirus Vaccine Customer List
Table 58. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Sharp & Dohme Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Merck Sharp & Dohme Main Business
Table 76. Merck Sharp & Dohme Latest Developments
Table 77. GSK Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Bharat Biotech Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. Lanzhou Biological Products Research Institute Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Lanzhou Biological Products Research Institute Main Business
Table 91. Lanzhou Biological Products Research Institute Latest Developments
Table 1. Oral Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oral Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Combination Vaccines
Table 5. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Oral Live Attenuated Rotavirus Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Oral Live Attenuated Rotavirus Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Oral Live Attenuated Rotavirus Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Oral Live Attenuated Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral Live Attenuated Rotavirus Vaccine Products Offered
Table 22. Oral Live Attenuated Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Oral Live Attenuated Rotavirus Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Oral Live Attenuated Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Oral Live Attenuated Rotavirus Vaccine
Table 53. Key Industry Trends of Oral Live Attenuated Rotavirus Vaccine
Table 54. Oral Live Attenuated Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral Live Attenuated Rotavirus Vaccine Distributors List
Table 57. Oral Live Attenuated Rotavirus Vaccine Customer List
Table 58. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Oral Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Oral Live Attenuated Rotavirus Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Oral Live Attenuated Rotavirus Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Sharp & Dohme Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Merck Sharp & Dohme Main Business
Table 76. Merck Sharp & Dohme Latest Developments
Table 77. GSK Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Bharat Biotech Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. Lanzhou Biological Products Research Institute Basic Information, Oral Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Lanzhou Biological Products Research Institute Main Business
Table 91. Lanzhou Biological Products Research Institute Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Live Attenuated Rotavirus Vaccine
Figure 2. Oral Live Attenuated Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Oral Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Vaccines
Figure 12. Product Picture of Combination Vaccines
Figure 13. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type in 2023
Figure 14. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Oral Live Attenuated Rotavirus Vaccine Consumed in Hospitals and Clinics
Figure 16. Global Oral Live Attenuated Rotavirus Vaccine Market: Hospitals and Clinics (2019-2024) & (K Dose)
Figure 17. Oral Live Attenuated Rotavirus Vaccine Consumed in Vaccination Sites
Figure 18. Global Oral Live Attenuated Rotavirus Vaccine Market: Vaccination Sites (2019-2024) & (K Dose)
Figure 19. Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2023)
Figure 20. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application in 2023
Figure 21. Oral Live Attenuated Rotavirus Vaccine Sales by Company in 2023 (K Dose)
Figure 22. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company in 2023
Figure 23. Oral Live Attenuated Rotavirus Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 28. Americas Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 30. APAC Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 32. Europe Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Oral Live Attenuated Rotavirus Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Oral Live Attenuated Rotavirus Vaccine
Figure 73. Industry Chain Structure of Oral Live Attenuated Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Oral Live Attenuated Rotavirus Vaccine
Figure 2. Oral Live Attenuated Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Live Attenuated Rotavirus Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Oral Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Vaccines
Figure 12. Product Picture of Combination Vaccines
Figure 13. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type in 2023
Figure 14. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Oral Live Attenuated Rotavirus Vaccine Consumed in Hospitals and Clinics
Figure 16. Global Oral Live Attenuated Rotavirus Vaccine Market: Hospitals and Clinics (2019-2024) & (K Dose)
Figure 17. Oral Live Attenuated Rotavirus Vaccine Consumed in Vaccination Sites
Figure 18. Global Oral Live Attenuated Rotavirus Vaccine Market: Vaccination Sites (2019-2024) & (K Dose)
Figure 19. Global Oral Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2023)
Figure 20. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application in 2023
Figure 21. Oral Live Attenuated Rotavirus Vaccine Sales by Company in 2023 (K Dose)
Figure 22. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Company in 2023
Figure 23. Oral Live Attenuated Rotavirus Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 28. Americas Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 30. APAC Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 32. Europe Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Oral Live Attenuated Rotavirus Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Oral Live Attenuated Rotavirus Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Oral Live Attenuated Rotavirus Vaccine
Figure 73. Industry Chain Structure of Oral Live Attenuated Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Application (2025-2030)
